Walleye Capital
HLF icon

Walleye Capital’s Herbalife HLF Stock Holding History

Walleye Capital’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$94.2K Sell
6,400
-13,300
-68% -$217K ﹤0.01% 3696
2025
Q4 		$254K Buy
+19,700
New +$209K ﹤0.01% 3412
2025
Q1 		– Sell
-59,900
Closed -$401K – 4597
2024
Q4 		$401K Sell
59,900
-216,000
-78% -$1.6M ﹤0.01% 3172
2024
Q3 		$1.98M Buy
275,900
+39,200
+17% +$361K ﹤0.01% 1962
2024
Q2 		$2.46M Buy
236,700
+209,400
+767% +$2.09M ﹤0.01% 1911
2024
Q1 		$274K Buy
27,300
+10,700
+64% +$115K ﹤0.01% 3735
2023
Q4 		$253K Sell
16,600
-5,100
-24% -$70.4K ﹤0.01% 3503
2023
Q3 		$304K Sell
21,700
-19,800
-48% -$299K ﹤0.01% 3230
2023
Q2 		$549K Buy
41,500
+37,200
+865% +$506K ﹤0.01% 2369
2023
Q1 		$69.2K Buy
+4,300
New +$76K ﹤0.01% 3085
2019
Q4 		– Sell
-1,800
Closed -$68K – 1988
2019
Q3 		$68K Sell
1,800
-8,100
-82% -$316K ﹤0.01% 1523
2019
Q2 		$423K Buy
9,900
+8,900
+890% +$421K 0.05% 569
2019
Q1 		$53K Buy
+1,000
New +$57.4K 0.01% 1191

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Walleye Capital's HLF Position: Q1 2026 in Review

Walleye Capital reduced its Herbalife (HLF) stake by 66% in Q1 2026, selling an estimated $513K and leaving 15,922 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3235.

Walleye Capital first reported a position in HLF in Q1 2019 and has held it in 20 quarters since. The position peaked at $2.27M in Q2 2024. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Walleye Capital held 15,922 shares of Herbalife worth $234K as of Q1 2026.
  • Walleye Capital sold 31,403 Herbalife shares in Q1 2026, an estimated $513K.
  • Herbalife made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3235 holding.
  • Walleye Capital first reported a position in Herbalife in Q1 2019 and has held it in 20 quarters since.
  • Walleye Capital's Herbalife position peaked at $2.27M in Q2 2024.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.